Literature DB >> 11901244

Cognition and white matter lesions.

David W Desmond1.   

Abstract

Although it is recognized that ischemic stroke is a potent risk factor for vascular dementia, the influence of white matter lesions (WML) on cognitive function is less clear. In community-based MRI studies that have administered mental status tests to subjects who were free of clinically evident neurologic disease, a weak relationship between WML and generalized cognitive function has been reported. In studies that have administered neuropsychological test batteries, a stronger and more specific association has been recognized between WML and deficits in executive function, most likely due to the involvement of frontal-subcortical pathways. Cognitive deficits may be related to the total volume of the WML, with a threshold perhaps needing to be surpassed before such deficits are evident, but it is likely that the location of the WML also plays a role, with that threshold varying in association with the distribution of the lesions. Potential confounders of the results of previous studies include small, strategically located subcortical infarctions that may be masked by more extensive WML and other comorbid neurologic disorders, particularly Alzheimer's disease. Future studies should be prospective, utilize standardized methods for structural and functional brain imaging, and administer comprehensive neuropsychological assessments in order to more rigorously investigate the relationship between evolving WML and declining cognitive functions. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 11901244     DOI: 10.1159/000049151

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  36 in total

1.  An MRI-based semiquantitative index for the evaluation of brain atrophy and lesions in Alzheimer's disease, mild cognitive impairment and normal aging.

Authors:  Wei Chen; Xiaowei Song; Yunting Zhang; Sultan Darvesh; Ningnannan Zhang; Ryan C N D'Arcy; Sandra Black; Kenneth Rockwood
Journal:  Dement Geriatr Cogn Disord       Date:  2010-08-21       Impact factor: 2.959

2.  Imaging neurotoxicity: is a picture worth a thousand words?

Authors:  Denise D Correa; Lauren E Abrey
Journal:  AJNR Am J Neuroradiol       Date:  2005-02       Impact factor: 3.825

3.  Diffusion tensor imaging identifies deficits in white matter microstructure in subjects with type 1 diabetes that correlate with reduced neurocognitive function.

Authors:  Christopher T Kodl; Daniel T Franc; Jyothi P Rao; Fiona S Anderson; William Thomas; Bryon A Mueller; Kelvin O Lim; Elizabeth R Seaquist
Journal:  Diabetes       Date:  2008-08-11       Impact factor: 9.461

4.  Morphometry demonstrates loss of cortical thickness in cerebral microangiopathy.

Authors:  Christoph Preul; Gabriele Lohmann; Margret Hund-Georgiadis; Thomas Guthke; D Yves von Cramon
Journal:  J Neurol       Date:  2005-02-23       Impact factor: 4.849

Review 5.  MRI-detected white matter lesions: do they really matter?

Authors:  Reinhold Schmidt; Anja Grazer; Christian Enzinger; Stefan Ropele; Nina Homayoon; Aga Pluta-Fuerst; Petra Schwingenschuh; Petra Katschnig; Margherita Cavalieri; Helena Schmidt; Christian Langkammer; Franz Ebner; Franz Fazekas
Journal:  J Neural Transm (Vienna)       Date:  2011-02-22       Impact factor: 3.575

Review 6.  Peroxisome proliferator-activated receptor γ (PPARγ): A master gatekeeper in CNS injury and repair.

Authors:  Wei Cai; Tuo Yang; Huan Liu; Lijuan Han; Kai Zhang; Xiaoming Hu; Xuejing Zhang; Ke-Jie Yin; Yanqin Gao; Michael V L Bennett; Rehana K Leak; Jun Chen
Journal:  Prog Neurobiol       Date:  2017-10-12       Impact factor: 11.685

7.  A quantitative MR imaging assessment of leukoencephalopathy in children treated for acute lymphoblastic leukemia without irradiation.

Authors:  Wilburn E Reddick; John O Glass; Kathleen J Helton; James W Langston; Chin-Shang Li; Ching-Hon Pui
Journal:  AJNR Am J Neuroradiol       Date:  2005-10       Impact factor: 3.825

8.  MR imaging-based volumetry in patients with early-treated phenylketonuria.

Authors:  Nadine H Pfaendner; Gitta Reuner; Joachim Pietz; Gregor Jost; Dietz Rating; Vincent A Magnotta; Alexander Mohr; Bodo Kress; Klaus Sartor; Stefan Hähnel
Journal:  AJNR Am J Neuroradiol       Date:  2005-08       Impact factor: 3.825

Review 9.  Demyelination as a rational therapeutic target for ischemic or traumatic brain injury.

Authors:  Hong Shi; Xiaoming Hu; Rehana K Leak; Yejie Shi; Chengrui An; Jun Suenaga; Jun Chen; Yanqin Gao
Journal:  Exp Neurol       Date:  2015-03-24       Impact factor: 5.330

Review 10.  Hypertension and cognitive function: pathophysiologic effects of hypertension on the brain.

Authors:  Teri A Manolio; Jean Olson; W T Longstreth
Journal:  Curr Hypertens Rep       Date:  2003-06       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.